ReviewPharmacoEconomics2023

Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Willem Witlox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.